chr9-37762586-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_144964.4(TRMT10B):āc.196C>Gā(p.Gln66Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000693 in 1,586,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144964.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRMT10B | NM_144964.4 | c.196C>G | p.Gln66Glu | missense_variant | 3/9 | ENST00000297994.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRMT10B | ENST00000297994.4 | c.196C>G | p.Gln66Glu | missense_variant | 3/9 | 1 | NM_144964.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151784Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000234 AC: 5AN: 213610Hom.: 0 AF XY: 0.00000875 AC XY: 1AN XY: 114288
GnomAD4 exome AF: 0.00000697 AC: 10AN: 1434916Hom.: 0 Cov.: 30 AF XY: 0.00000844 AC XY: 6AN XY: 710684
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151902Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | The c.196C>G (p.Q66E) alteration is located in exon 3 (coding exon 2) of the TRMT10B gene. This alteration results from a C to G substitution at nucleotide position 196, causing the glutamine (Q) at amino acid position 66 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at